Navigation Links
Delcath Establishes Queensbury, NY Operations Facility
Date:9/3/2009

NEW YORK, Sept. 3 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), a Manhattan headquartered medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that it has signed a three-year lease with the option to buy on a 10,000 square foot facility in Queensbury, New York in which it plans to locate manufacturing of its Percutaneous Hepatic Perfusion (PHP(TM)) System. The company anticipates hiring approximately 20 people at this facility by the end of 2009 to establish manufacturing, distribution, research and development capabilities.

"Queensbury is within the fabled upstate-New York region long known as 'Catheter Valley,'" said Eamonn Hobbs, President and CEO of Delcath Systems. "Major medical device companies have located their catheter operations there for decades. As a result, the local labor force is well acquainted with the manufacturing requirements that Delcath will face as it ramps up to full-scale production of the PHP System(TM). And I am personally very excited to be building this business in a region that I know so well."

The Delcath PHP System(TM) is presently being tested in a Phase III study for the regional delivery of melphalan to the liver to treat patients with metastatic cutaneous and ocular melanoma who have unresectable tumors in the liver. The System is designed to deliver significantly higher doses of anti-cancer drugs to a patient's liver while minimizing entry of the drugs into the rest of the patient's circulation. This isolation limits toxicities which result from systemic chemotherapy treatments.

Complete enrollment in the trial is expected by the end of October 2009, with CE Mark approval and a submission to the U.S. Food & Drug Admin
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Delcath Systems to Host Quarterly Update Conference Call
2. Delcath Systems to Host Quarterly Update Conference Call
3. Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress
4. Delcath Systems Provides Update on Progress
5. Delcath Systems, Inc. Announces Patient Recruitment Exceeds 90%
6. FDA Grants Delcath Orphan-Drug Designation for Doxorubicin
7. LifeNet Health Establishes The Skin & Wound Allograft Institute
8. Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology
9. AT&T Establishes New Network Services for Leading Medical Liability Insurer
10. Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation
11. Sentry Telecare Establishes Partnering Program to Market Telephone Check-in and Personal Emergency Response Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... for the very healthy. Astronauts are selected for ... psychological standards to prepare them for any unknown ... average people can now fly for enjoyment. The ... about what medical conditions or diseases should be ... most medical conditions have never been studied for ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Functional Fitness ... Ritchie and Dr. Cody Sipe that is helping middle-aged adults ... and longevity has caught the attention of Shane Michaels, prompting ... in their 50s, 60s, or even 70s what would be ... on a day-to-day basis, they would probably answer that the ...
(Date:9/17/2014)... -- Social networking sites can help people lose weight, ... are obese, sites like Twitter and Facebook can be ... as well as peers, researchers found. "One advantage ... it offers the potential to be much more cost ... traditional approaches," the study,s lead author, Dr. Hutan Ashrafian, ...
(Date:9/17/2014)... 2014 The Oliver Law Group P.C. ... caused by Non-Sterile Other-Sonic Ultrasound Transmission Gel to ... options for legal recourse. Other-Sonic ultrasound gel was recalled ... March 2012, after the product was linked to a ... Hospital in Royal Oak, Michigan . While victims of ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Catalent ... delivery technologies and development solutions for drugs, biologics ... of OptiPact™, an integrated service and technology offer ... and provided from the company’s 450,000 sq. ft. ... Catalent’s ability to integrate optimal formulation, development, analytical ...
Breaking Medicine News(10 mins):Health News:Space: The final frontier… open to the public 2Health News:Functional Fitness Solution: Review Exposes Dr. Dan Ritchie and Dr. Cody Sipe’s Guide to Everyday Fitness for Longevity 2Health News:Social Networking Sites Can Help Obese Lose Weight: Study 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:New OptiPact™ Technology Introduced by Catalent 2
... ATLANTA, Aug. 11 MinuteClinic, the pioneer and largest provider ... a first-of-its kind rapid conjunctivitis (pink-eye) test at its 23 locations ... test is a pilot project conducted in partnership with Rapid Pathogen ... at a future date in its clinic locations in 25 states. ...
... PITTSBURGH, Aug. 11 Foundation Radiology ... headquartered in Pittsburgh, is pleased to announce its exclusive imaging ... , Uniontown Hospital, a 224-bed hospital, has ... of Fayette County and surrounding areas for over 100 years. ...
... , SOMERSET, N.J., Aug. 11 ... healthcare and administrative staffing services, will announce its third quarter financial results ... before the market opens. TeamStaff will host a conference call for ... Interested parties may participate in the call by dialing (877) ...
... , , , SAN ... CXM ) today reported its financial results for its second ... future outlook. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ... since first quarter 2009 financial report and highlights included (1) ...
... , , NEW YORK, Aug. ... a contract by ValueOptions(R), a behavioral health care company headquartered ... services for ValueOptions(R) at risk Plans, which cover approximately 1.5 ... Medicaid members that have other healthcare coverage, and recover overpayments ...
... MIAMI, Aug. 11 ECHealthInsurance.com a Florida based health ... month to help Floridians. According to Vice President of Marketing ... August is the only month every year that is open ... seasonality spikes of Florida our summer is much slower as ...
Cached Medicine News:Health News:MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes 2Health News:MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes 3Health News:Foundation Radiology Group Signs Exclusive Contract With Uniontown Hospital 2Health News:TeamStaff, Inc. To Announce Third Quarter Results 2Health News:TeamStaff, Inc. To Announce Third Quarter Results 3Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 2Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 3Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 4Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 5Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 6Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 7Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 8Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 9Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 10Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 11Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 12Health News:Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 13Health News:ValueOptions(R) Awards Coordination of Benefits and Overpayment Services Contract to HMS 2Health News:Florida Health Insurance Brokerage to Donate Month of August to Help Residents of Florida 2
(Date:9/17/2014)... , Sept. 17, 2014 Isis ... that it has earned a $4 million milestone ... ) associated with the initiation of a Phase ... multi-drug resistant (MDR), gram-negative bacterial infections.  The Phase ... to evaluate the efficacy and safety of plazomicin ...
(Date:9/17/2014)... Sutro Biopharma, a biopharmaceutical company developing antibody ... of Merck KGaA, Darmstadt, Germany , ... United States and Canada ... develop antibody drug conjugates (ADCs). ADCs are composed of ... is thought to specifically target and deliver the cytotoxic ...
(Date:9/17/2014)... , Sept. 17, 2014  Fortune Oil and Gas, ... its name to Manzo Pharmaceuticals, Inc. with the symbol ... effect today, September 17, 2014. Also taking effect today ... The approval is a pivotal event in the company,s ... Manzo explained, "We could not proceed with the plan ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 2Isis Pharmaceuticals Earns $4 Million from Achaogen for the Initiation of a Phase 3 Study of Plazomicin 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 2Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective 3
... androgen secreted into the blood. In males, ... of the testes; in females ca. 50% ... of androstenedione, ca. 25% from the ovary ... The Testosterone ELISA KIT is based on ...
Microalbumin EIA Lipid / Protein Quantification 024-IDC-12...
Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6...
Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease...
Medicine Products: